<DOC>
	<DOCNO>NCT01160289</DOCNO>
	<brief_summary>The primary purpose study compare efficacy LY2452473 + tadalafil tadalafil alone improve erectile function ( EF ) men erectile dysfunction ( ED ) incompletely respond tadalafil alone .</brief_summary>
	<brief_title>A Study LY900010 Erectile Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Tadalafil</mesh_term>
	<criteria>Inclusion Criteria include : Ambulatory men History Erectile Dysfunction least 3 month duration History incomplete response phosphodiesterase type 5 inhibitor ( PDE5i ) maximum tolerate dose within label Anticipate female sexual partner throughout duration study Are willing able make least 4 sexual intercourse attempt female sexual partner 4week segment study Agree use birth control study 60 day study , unless female partner postmenopausal Agree use Erectile Dysfunction treatment , include herbal treatment , study 96 hour last dose study drug Screening laboratory test within normal limit except testosterone Without language barrier , reliable willing follow study procedure ProstateSpecific Antigen ( PSA ) less 10 ng/ml . Men PSA great 4 less 10 ng/ml must documentation negative histological biopsy carcinoma prostate within 12 month prior screen Exclusion Criteria include : History penile implant History response injection therapy Erectile Dysfunction History radical prostatectomy pelvic surgery subsequent failure achieve erection Exhibit presence clinically significant penile deformity opinion investigator History prior sexual legal conviction Bilateral hip replacement History cancer within previous 5 year , except excise superficial lesion basal cell carcinoma squamous cell carcinoma skin Chronic stable angina currently treat longacting nitrate Chronic stable angina require treatment shortacting nitrate within 90 day prior screen Angina occur sexual intercourse 6 month prior screen Unstable angina within 6 month prior screen Myocardial infarction coronary artery bypass graft surgery within 90 day prior screen Angioplasty stent placement within 90 day prior screen Congestive heart failure within 6 month prior screen History sudden cardiac arrest Supraventricular arrythmia uncontrolled ventricular response rest , history spontaneous induce sustained ventricular tachycardia , use automatic internal cardioverterdefibrillator An abnormality 12lead ECG opinion investigator place subject unacceptable risk study participation Systolic blood pressure great 170 less 90 mm Hg diastolic blood pressure great 100 less 50 mm Hg screening Hepatic , renal , HIV , clinically significant active neuropsychiatric disease History central nervous system injury ( include stroke spinal cord injury ) within 6 month prior screen Alcohol intake 5 unit great per day ( 1 unit = 12 ounce beer , 5 ounce wine , 1.5 ounce 80proof distilled spirit Receiving treatment antiandrogens 5alpha reductase inhibitor Anabolic steroid , calcitonin , oral bisphosphonates , Vitamin D great 50,000 IU/week , DHEA , steroidal supplement , nutritional product intend weight reduction performance enhance effect , herbal supplement within 7 day prior screen Currently treat potent cytochrome P450 ( CYP ) 3A4 inhibitor , systemic ketoconazole ritonavir , CYP3A4 inducer rifampicin</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2011</verification_date>
</DOC>